Skip to content

Cl-Pharm-IBS-ML-2026

Machine Learning-Based Phenotyping of IBS Patients Using Multidimensional Patient-Reported Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07809646
Enrollment
500
Registered
2026-09-09
Start date
2026-09-20
Completion date
2027-01-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IBS

Brief summary

The purpose of this study is to identify distinct subgroups (phenotypes) of Irritable Bowel Syndrome (IBS) patients. While traditional IBS classification relies mainly on bowel habits, this research uses a multidimensional questionnaire to capture clinical symptoms, psychological factors, diet triggers, sleep quality, and digital behaviors. By applying advanced machine learning algorithms to these patient-reported outcomes, the study aims to uncover hidden patterns that can help customize future treatments and improve patient care.

Interventions

OTHERQuestionnaire and Physical Exam

ONLINE QUESTIONNAIRE

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Participants aged 18 years or older. * Formal physician-confirmed diagnosis of Irritable Bowel Syndrome (IBS). * Ability to access and complete the digital multidimensional questionnaire. * Willingness to provide digital informed consent.

Exclusion criteria

* Presence of organic gastrointestinal diseases (e.g., Inflammatory Bowel Disease, celiac disease, or colorectal cancer). * Presence of alarm/red flag symptoms (e.g., nocturnal symptoms waking the patient). * Incomplete or inconsistent questionnaire responses.

Design outcomes

Primary

MeasureTime frame
Distinct patient subgroups (phenotypes) identified through unsupervised machine learning clustering algorithms.At the time of questionnaire completion (Baseline)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026